SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-031617
Filing Date
2021-12-15
Accepted
2021-12-15 17:27:12
Documents
17
Period of Report
2021-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57545
2 ex3-1.htm EX-3.1 130750
3 ex4-1.htm EX-4.1 113309
4 ex4-2.htm EX-4.2 112504
5 ex10-1.htm EX-10.1 206095
6 ex99-1.htm EX-99.1 19823
  Complete submission text file 0001493152-21-031617.txt   953949

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pulm-20211215.xsd EX-101.SCH 3028
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pulm-20211215_lab.xml EX-101.LAB 34240
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pulm-20211215_pre.xml EX-101.PRE 22361
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3713
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 211495140
SIC: 2834 Pharmaceutical Preparations